GRCL: Gracell Biotechnologies Ltd Net earnings per share (EPS TTM)

Public company logo of Gracell Bio (GRCL)

Gracell Biotechnologies (GRCL) aims for global leadership in CAR-T therapy for blood cancer through the expansion of clinical trials. The rolling earnings per share indicator demonstrates profit dynamics, where the value -1.01 captures the metric level. The innovative FasTCAR platform accelerates cell production, ensuring high margins and financial support from a pharmaceutical behemoth for the rapid market launch of drugs.

GRCL (Gracell Biotechnologies) Net earnings per one share for the last twelve months history from 07/04/2022 to 03/03/2024

Gracell Bio - analytical breakdowns and key metrics (GRCL)

- share price and expert price forecast:
Stock Quotes Gracell Biotechnologies|GRCL - Fair Value Consensus
- market capitalization information:
Market Capitalization Gracell Biotechnologies Inc.|GRCL - Real Price to Acquire Entire Company
- business book valuation details:
Book Value per Share Gracell Biotechnologies|GRCL - Total Stockholders' Equity|Market Value to Book Value Ratio gracellbio.com|GRCL - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity Gracell Biotechnologies|GRCL - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Gracell Biotechnologies Ltd|GRCL - Aggregate Debt Obligations|Debts to Book Capitalization Gracell Biotechnologies Inc.|GRCL - Long-Term Indebtedness|Company Short-Term Debts Gracell Biotechnologies|Quick Liquidity gracellbio.com
- net income and valuation multiples indicators:
GRCL - Company Profit|Projected Future Earnings Gracell Biotechnologies|GRCL - Market Cap to Earnings|Projected Price to Earnings Gracell Biotechnologies Inc.|GRCL - Growth-Adjusted Payback Ratio|Enterprise Value to EBITDA Ratio Gracell Biotechnologies Inc.|GRCL - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Gracell Biotechnologies|GRCL - Earnings per share for the trailing year|Quarterly EPS earnings growth gracellbio.com|GRCL - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Gracell Biotechnologies
- revenue and sales proceeds data:
GRCL - Company Sales Revenue|Projected Sales Volume Gracell Biotechnologies|GRCL - P/S Multiple|Price-to-Projected Revenue Ratio Gracell Biotechnologies Inc.
General company analysis:Gracell Biotechnologies (GRCL)
Mass-produced product of Gracell

Establishing a long-term position requires an assessment of the risk of capital freezing during market downturns. The strong pricing power of Gracell Biotechnologies (GRCL), driven by its rapid CAR-T cell production method, creates a foundation for revenue growth. The 12-month net income per share trend for Gracell Biotechnologies (GRCL) reflects the final financial result distributed across the total volume of issuance. This indicator compares the actual supply of securities with the real demand for a share of profits. The stability of this metric confirms the operational resilience of the business.

Analysis of competing companies

LEGN: Net earnings per share for the last 12 months|Earnings per share for the trailing year SANA (sana.com)|AUTL: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Allogene Therapeutics, Inc.|RNAC (Cartesian Therapeutics Inc) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Cellectis Biotherapeutics CLLS|Earnings per share for the last twelve months Caribou Biosciences (CRBU)|Earnings per share for the last twelve months TIL (instilbio.com)|Earnings per share for the last twelve months Genenta Science GNTA|Century Tx - Earnings per share for the last twelve months|JSPR: Net earnings per share for the last 12 months|Earnings per share for the trailing year SNTI (Senti Biosciences, Inc.)|ADAP: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year CERo Therapeutics Holdings CERO|TCRT (Alaunos Therapeutics Inc.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Achilles Tx ACHL|Earnings per share for the last twelve months Cargo Therapeutics (CRGX)|Poseida Corp - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) TSVT (2seventy bio, Inc.)